Moraga Biotechnology signs licensing agreement with Pharmacells
The licensing agreement provides Pharmacells access to Moraga’s proprietary adult stem cell technology for banking its blastomere-like stem cells (BLSCs) that have been isolated, processed, and cryopreserved from
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.